Rankings
▼
Calendar
FDMT FY 2017 Earnings — 4D Molecular Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FDMT
4D Molecular Therapeutics, Inc.
$427M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
Gross Profit
-$8M
-134.4% margin
Operating Income
-$11M
-194.7% margin
Net Income
-$11M
-193.8% margin
EPS (Diluted)
$-0.76
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$8M
Stock-Based Comp.
$256,000
Balance Sheet
Total Assets
$27M
Total Liabilities
$47M
Stockholders' Equity
-$20M
Cash & Equivalents
$24M
← Q1 2018
All Quarters
